New Alzheimer’s drug raises hopes — along with questions

FHS
August 11, 2023
10:48 am

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment.

More Patients Participate in Cancer Treatment Trials Than Previously Estimated

Participation in cancer treatment clinical trials was higher than historical estimates, according to a national sample of data from the Commission on Cancer. From 2013

May 14, 2024

Wellness influencers show higher rates of vaccine opposition on social media

Wellness influencers showed higher rates of vaccine opposition on social media compared to other users’ accounts, according to a new University of Michigan study.

December 23, 2024

Study finds plant proteins improve rest, animal proteins may disrupt

Plant protein intake is associated with improved sleep quality, while animal protein, particularly from processed red meat and poultry, is linked to worse sleep, with

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.